Showing results (261-270 of 715) with videos related to
Sort By:
Pageof 72
Virology|April 23, 2017
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loadsPaige Charlins, Kimberly Schmitt, Leila Remling-Mulder, et al.AIDS (London, England)|June 23, 2009
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patientsPriscilla Y Hsue, Peter W Hunt, Yuaner Wu, et al.Nature|May 7, 2010
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionAndrej Kosmrlj, Elizabeth L Read, Ying Qi, et al.Annals of the New York Academy of Sciences|December 2, 2016
Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?Ronald A Kohanski, Steven G Deeks, Claudia Gravekamp, et al.Frontiers in Immunology|February 13, 2023
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4Katie Fisher, Timothy E Schlub, Zoe Boyer, et al.Circulation. Heart Failure|November 26, 2009
Impact of HIV infection on diastolic function and left ventricular massPriscilla Y Hsue, Peter W Hunt, Jennifer E Ho, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoirBiswajit Das, Curtis Dobrowolski, Benjamin Luttge, et al.The Journal of Infectious Diseases|November 30, 2013
HIV antibody characterization as a method to quantify reservoir size during curative interventionsPeter D Burbelo, Ahmad Bayat, Craig S Rhodes, et al.Journal of the American Heart Association|April 30, 2019
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected AdultsArjun Sinha, Yifei Ma, Rebecca Scherzer, et al.Frontiers in Immunology|April 14, 2023
Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapyChris Y Chiu, Maya D Schou, James H McMahon, et al.Pageof 72